Risk/Reward Rating: Neutral (look to accumulate on price weakness)
Aspen Aerogels yesterday announced a $75 million investment by a subsidiary of Koch Investments Group at $21.663 per share. Aspen is on the cusp of what could be an incredible opportunity in many secular growth industries. Donald R. Young, Aspen’s President and CEO, believes the company has the opportunity to double sales every two years through the end of the decade. The Koch investment resolves the primary constraint facing Aspen, the need for additional long-term growth capital to build out capacity in order to penetrate new markets and meet demand.
Continue reading this report with a stoxdox membership.